← SynDRA
NGB-2904
SynDRA canonical compound SYN0050346 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD3 |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- DRD3 ANTAGONIST
Cross-references
Synonyms
- NGB2904
- Ngb 2904
- RefChem:927695
- GTPL6674
- orb1304984
- SCHEMBL7762650
- CHEBI:92089
- BDBM50071959
- EX-A12316
- AKOS040749022
- EBC-521181
- NCGC00167804-01
- DA-76154
- HY-12697
- MS-29174
- CS-0012274
- F81743
- T28167
- L016292
- BRD-K05181084-003-02-9
- BRD-K05181084-003-03-7
- NGB 2904 hydrochloride, >=98% (HPLC)
- MFCD09971107
- T23065
- PFIWYJNBKGCVFM-UHFFFAOYSA-N
- NGB 2904 hydrochloride
- NGB 2904 (hydrochloride)
- MS-33106
- orb1909947
- orb1704300
- SCHEMBL29407111
- C28H30Cl3N3O
- PHA06111
- GLXC-10532
- SCHEMBL7762562
- DA-76155
- HY-12697A
- AKOS024457210
- CS-0012275
Look up NGB-2904 in the interactive SynDRA portal →